Literature DB >> 8770558

Human germinal center CD4+CD57+ T cells act differently on B cells than do classical T-helper cells.

F Bouzahzah1, A Bosseloir, E Heinen, L J Simar.   

Abstract

We have isolated two subtypes of helper T cells from human tonsils: CD4+CD57+ cells, mostly located in the germinal center (GC), and CD4+CD57- cells, distributed through the interfollicular areas but also present in the GC. In a functional study, we have compared the capacities of these T-cell subtypes to stimulate B cells in cocultures. In order to block T-cell proliferation while maintaining their activation level, we pretreated isolated T cells with mitomycin C prior to culture in the presence of B cells and added polyclonal activators such as PHA and Con A, combined or not with IL-2. Contrary to CD4+ CD57- cells, CD4+CD57+ cells did not markedly enhance B-cell proliferation. Even when sIgD.B cells typical of germinal center cells were tested, the CD4+CD57+ cells had no significant effect. This is in accordance with the location of these cells: They mainly occupy the light zones of the GC where few B cells divide. Even when added to preactivated, actively proliferating cells, CD4+CD57 cells failed to modulate B-cell multiplication. On the supernatants of B-cell-T-cell cocultures, we examined by the ELISA technique the effect of T cells on Ig synthesis. Contrary to CD57+ T cells, whose effect was strong, CD57- T cells weakly stimulated Ig synthesis. More IgM than IgG was generally found. Because CD57 antigen is a typical marker of natural killer cells, we tested the cytolytic activity of tonsillar CD4+CD57+ cells on K562 target cells. Unlike NK cells, neither CD4+CD57+ nor CD4+CD57- cells exhibit any cytotoxicity. Thus, germinal center CD4+CD57+ cells are not cytolytic and do not strongly stimulate either B-cell proliferation or Ig secretion. CD4+CD57- cells, however, enhance B-cell proliferation and differentiation, thus acting like the classical helper cells of the T-dependent areas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8770558      PMCID: PMC2275954          DOI: 10.1155/1995/76790

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  6 in total

1.  Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).

Authors:  N Porakishvili; T Roschupkina; T Kalber; A P Jewell; K Patterson; K Yong; P M Lydyard
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 2.  T cells that promote B-Cell maturation in systemic autoimmunity.

Authors:  Jason S Weinstein; Sairy G Hernandez; Joe Craft
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

3.  Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses.

Authors:  Hyung W Lim; Peter Hillsamer; Chang H Kim
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

4.  Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination.

Authors:  Donato Amodio; Nicola Cotugno; Giulia Macchiarulo; Salvatore Rocca; Yiannis Dimopoulos; Maria Rita Castrucci; Rita De Vito; Filippo M Tucci; Adrian B McDermott; Sandeep Narpala; Paolo Rossi; Richard A Koup; Paolo Palma; Constantinos Petrovas
Journal:  J Immunol       Date:  2017-12-13       Impact factor: 5.422

5.  Altered immune cell follicular dynamics in HIV infection following influenza vaccination.

Authors:  Eirini Moysi; Suresh Pallikkuth; Lesley R De Armas; Louis E Gonzalez; David Ambrozak; Varghese George; David Huddleston; Rajendra Pahwa; Richard A Koup; Constantinos Petrovas; Savita Pahwa
Journal:  J Clin Invest       Date:  2018-06-18       Impact factor: 14.808

6.  Human CD57+ germinal center-T cells are the major helpers for GC-B cells and induce class switch recombination.

Authors:  Jong R Kim; Hyung W Lim; Seung G Kang; Peter Hillsamer; Chang H Kim
Journal:  BMC Immunol       Date:  2005-02-04       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.